Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice.

MLA

Lucie Mondoulet, et al. “Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice.” PLoS ONE, vol. 7, no. 2, Jan. 2012, p. e31967. EBSCOhost, https://doi.org/10.1371/journal.pone.0031967.

APA

Lucie Mondoulet, Vincent Dioszeghy, Thibaut Larcher, Mélanie Ligouis, Véronique Dhelft, Emilie Puteaux, Yan Cherel, Franck Letourneur, Christophe Dupont, & Pierre-Henri Benhamou. (2012). Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS ONE, 7(2), e31967. https://doi.org/10.1371/journal.pone.0031967

Chicago

Lucie Mondoulet, Vincent Dioszeghy, Thibaut Larcher, Mélanie Ligouis, Véronique Dhelft, Emilie Puteaux, Yan Cherel, Franck Letourneur, Christophe Dupont, and Pierre-Henri Benhamou. 2012. “Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice.” PLoS ONE 7 (2): e31967. doi:10.1371/journal.pone.0031967.